Breaking News Instant updates and real-time market news.

2018-11-06 06:28:48 LLY Eli Lilly $110.20 3.46 (3.24%) 06:28 11/06/18 11/06 06:28 11/06/18 06:28	Eli Lilly reports Q3 Humalog revenue down 5% to $664.6M For the third quarter of 2018, Alimta generated worldwide revenue of $520.5 million, which increased 1 percent compared with the third quarter of 2017. For the third quarter of 2018, worldwide Cialis revenue decreased 17 percent to $467.1 million. For the third quarter of 2018, worldwide Humulin revenue increased 7 percent compared with the third quarter of 2017, to $322.1 million. In the third quarter of 2018, worldwide animal health revenue totaled $772.7 million, an increase of 4 percent compared with the third quarter of 2017.	06 Nov 07 Nov 12 Nov
LLY Eli Lilly $110.20 3.46 (3.24%) 10/31/18 10/31/18 UPGRADE On The Fly: Top five analyst upgrades Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. General Electric (GE) upgraded to Buy from Neutral at UBS with analyst Steven Winoker saying he has conviction that new CEO Larry Culp can lead a turnaround of the business and his upside/downside analysis for shares now stands at a favorable 3:1 skew following the recent selloff. 2. Eli Lilly (LLY) upgraded to Neutral from Underperform at Credit Suisse. 3. Comerica (CMA) upgraded to Strong Buy from Outperform at Raymond James with analyst David Long saying the pullback in the sector provides more attractive risk/reward in Comerica shares and said its deposit base is relatively attractive given its high 52% composition of noninterest-bearing deposits, 87.5% loan/deposit ratio, and low 21% cumulative deposit beta. 4. Denny's (DENN) upgraded to Overweight from Equal Weight at Stephens with analyst Will Slabaugh saying the company's transition to a 95%-plus franchised model, and the improving return on invested capital that accompanies the transition, should "command a higher valuation." 5. ASML (ASML) upgraded to Buy from Hold at Santander. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here. 10/31/18 HCWC 10/31/18 NO CHANGE Target $24 HCWC Buy Dicerna price target raised to $24 after Lilly, Alexion pacts at H.C. Wainwright H.C. Wainwright analyst Ed Arce raised his price target on Dicerna (DRNA) shares to $24 from $20 after the company announced collaborations with Eli Lilly (LLY) and Alexion Pharmaceuticals (ALXN). Arce views these partnerships as further strong validation of Dicerna's GalXC RNAi platform and keeps a Buy rating on the shares. 10/31/18 FBCO 10/31/18 UPGRADE FBCO Neutral Eli Lilly upgraded to Neutral from Underperform at Credit Suisse 10/29/18 SBSH 10/29/18 NO CHANGE Target $30 SBSH Buy Dicerna price target raised to $30 from $27 at Citi Citi analyst Robyn Karnauskas said Dicerna's (DRNA) licensing and research collaboration with Eli Lilly (LLY) validates the former's RNAi platform and provides it with a meaningful cash infusion. The $200M upfront payment adds $3 to her discounted cash flow-derived price target, moving the target up to $30. Karnauskas keeps a Buy rating on Dicerna shares.

2018-11-06 06:28:48

LLY

Eli Lilly

$110.20: 3.46 (3.24%)

06:28

11/06/18

11/06

06:28

11/06/18

06:28

Eli Lilly reports Q3 Humalog revenue down 5% to $664.6M

For the third quarter of 2018, Alimta generated worldwide revenue of $520.5 million, which increased 1 percent compared with the third quarter of 2017. For the third quarter of 2018, worldwide Cialis revenue decreased 17 percent to $467.1 million. For the third quarter of 2018, worldwide Humulin revenue increased 7 percent compared with the third quarter of 2017, to $322.1 million. In the third quarter of 2018, worldwide animal health revenue totaled $772.7 million, an increase of 4 percent compared with the third quarter of 2017.

06
Nov
07
Nov
12
Nov

LLY Eli Lilly

$110.20: 3.46 (3.24%)

10/31/18

10/31/18: HCWC

10/31/18: FBCO

10/29/18: SBSH

TODAY'S FREE FLY STORIES

NTR Nutrien $54.57 1.22 (2.29%) 14:35 02/20/19 02/20 14:35 02/20/19 14:35 Options	Nutrien put volume heavy and directionally bearish » Bearish flow noted in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	24 Feb 24 Feb 27 Feb 27 Feb
14:35 02/20/19 02/20 14:35 02/20/19 14:35 General news	On the balance sheet: » On the balance sheet: the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
SSNLF Samsung $0.00 (0.00%) , VZ Verizon $55.67 0.24 (0.43%) 14:34 02/20/19 02/20 14:34 02/20/19 14:34 Periodicals	Samsung unveils Galaxy S10 5G, Verge reports » Samsung (SSNLF) intends… SSNLF Samsung $0.00 (0.00%) VZ Verizon $55.67 0.24 (0.43%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb 03 Mar 03 Mar 11 Mar 11 Mar
FDP Fresh Del Monte $29.80 0.53 (1.81%) 14:34 02/20/19 02/20 14:34 02/20/19 14:34 Hot Stocks	Breaking Hot Stocks news story on Fresh Del Monte » Fresh Del Monte trading… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
CYTK Cytokinetics $7.52 -0.17 (-2.21%) , AMGN Amgen $187.14 0.17 (0.09%) 14:27 02/20/19 02/20 14:27 02/20/19 14:27 Recommendations	Cytokinetics, Amgen analyst commentary » Piper reiterates… CYTK Cytokinetics $7.52 -0.17 (-2.21%) AMGN Amgen $187.14 0.17 (0.09%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Feb 21 Feb 21 Feb 28 Feb 01 Mar

GG Goldcorp $11.52 0.25 (2.22%) 14:25 02/20/19 02/20 14:25 02/20/19 14:25 Options	Goldcorp call volume above normal and directionally bullish » Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
14:25 02/20/19 02/20 14:25 02/20/19 14:25 General news	FX Action: The Dollar » FX Action: The Dollar… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial
SSNLF Samsung $0.00 (0.00%) , AAPL Apple $172.67 1.72 (1.01%) 14:23 02/20/19 02/20 14:23 02/20/19 14:23 Periodicals	Samsung unveils new foldable phone called Galaxy Fold, Verge reports » At Samsung's Galaxy… SSNLF Samsung $0.00 (0.00%) AAPL Apple $172.67 1.72 (1.01%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	01 Mar 01 Mar
FDP Fresh Del Monte $29.80 0.53 (1.81%) 14:20 02/20/19 02/20 14:20 02/20/19 14:20 Hot Stocks	Fresh Del Monte board suspends quarterly cash dividend » Fresh Del Monte Produce… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
14:20 02/20/19 02/20 14:20 02/20/19 14:20 General news	FOMC minutes to Januayr 29, 30 meeting: » FOMC minutes to Januayr… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial

NXTM NxStage Medical $29.99 0.35 (1.18%) , FMS Fresenius Medical $40.17 1.79 (4.66%) 14:18 02/20/19 02/20 14:18 02/20/19 14:18 Hot Stocks	FTC requires NxStage, Fresenius Medical to divest bloodline tubing assets » The Federal Trade… NXTM NxStage Medical $29.99 0.35 (1.18%) FMS Fresenius Medical $40.17 1.79 (4.66%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Feb 05 Mar 12 Mar
$NSD NASDAQ Market Internals $0.00 (0.00%) 14:17 02/20/19 02/20 14:17 02/20/19 14:17 Technical Analysis	NASDAQ market internals summary » Volume is average for… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
$NYE NYSE Market Internals $0.00 (0.00%) 14:16 02/20/19 02/20 14:16 02/20/19 14:16 Technical Analysis	NYSE market internals summary » Volume is average for… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ETSY Etsy $54.65 -0.65 (-1.18%) 14:15 02/20/19 02/20 14:15 02/20/19 14:15 Options	Etsy put volume heavy and directionally bearish » Bearish flow noted in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb 25 Feb 07 Mar 07 Mar
SPX S&P 500 $0.00 (0.00%) , SPY SPDR S&P 500 ETF Trust $278.60 0.71 (0.26%) 14:09 02/20/19 02/20 14:09 02/20/19 14:09 General news	'Almost all' Fed members wanted to announce plan to stop reducing assets » Minutes from the last… SPX S&P 500 $0.00 (0.00%) SPY SPDR S&P 500 ETF Trust $278.60 0.71 (0.26%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

SPX S&P 500 $0.00 (0.00%) , SPY SPDR S&P 500 ETF Trust $278.27 0.38 (0.14%) 14:06 02/20/19 02/20 14:06 02/20/19 14:06 General news	Fed saw 'variety of considerations' for 'patient approach to monetary policy' » Minutes from the last… SPX S&P 500 $0.00 (0.00%) SPY SPDR S&P 500 ETF Trust $278.27 0.38 (0.14%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
SPX S&P 500 $0.00 (0.00%) , SPY SPDR S&P 500 ETF Trust $278.32 0.43 (0.15%) 14:05 02/20/19 02/20 14:05 02/20/19 14:05 General news	Fed to continue monitoring economic developments for outlook implications » Minutes from the last… SPX S&P 500 $0.00 (0.00%) SPY SPDR S&P 500 ETF Trust $278.32 0.43 (0.15%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
SPX S&P 500 $0.00 (0.00%) , SPY SPDR S&P 500 ETF Trust $278.34 0.45 (0.16%) 14:02 02/20/19 02/20 14:02 02/20/19 14:02 General news	Fed sees 'sustained expansion of economic activity' as most likely outcome » Minutes from the last… SPX S&P 500 $0.00 (0.00%) SPY SPDR S&P 500 ETF Trust $278.34 0.45 (0.16%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
FDP Fresh Del Monte $29.97 0.7 (2.39%) 14:00 02/20/19 02/20 14:00 02/20/19 14:00 Hot Stocks	Breaking Hot Stocks news story on Fresh Del Monte » Fresh Del Monte trading… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
BHC Bausch Health $23.13 -2.04 (-8.10%) 14:00 02/20/19 02/20 14:00 02/20/19 14:00 Options	Dip buyer in Bausch Health Companies » Dip buyer in Bausch… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Feb 20 Feb 25 Feb 25 Feb 25 Feb 12 Mar 12 Mar

VLKAY Volkswagen $0.00 (0.00%) , AUDVF Audi AG $0.00 (0.00%) 13:59 02/20/19 02/20 13:59 02/20/19 13:59 Periodicals	Audi plans to cut 10% of management positions, Reuters reports » Audi (AUDVF),… VLKAY Volkswagen $0.00 (0.00%) AUDVF Audi AG $0.00 (0.00%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
TTD Trade Desk $146.31 -15.45 (-9.55%) 13:58 02/20/19 02/20 13:58 02/20/19 13:58 On The Fly	Trade Desk slides after analyst cuts rating ahead of quarterly results » Shares of Trade Desk… Open Full Text 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb 21 Feb 06 Mar 06 Mar
UA Under Armour $19.15 -0.23 (-1.19%) 13:55 02/20/19 02/20 13:55 02/20/19 13:55 Options	Under Armour put volume heavy and directionally bearish » Bearish flow noted in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	03 Mar 06 Mar
PM Philip Morris $85.42 2 (2.40%) 13:50 02/20/19 02/20 13:50 02/20/19 13:50 Earnings	Philip Morris repeats Q1 reported diluted EPS view of $1.00, consensus $1.01 » As communicated on… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
PM Philip Morris $85.42 2 (2.40%) 13:49 02/20/19 02/20 13:49 02/20/19 13:49 Earnings	Philip Morris reaffirms FY19 reported diluted EPS guidance of at least $5.37 » Philip Morris… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

Events

Earnings calls, analyst events, roadshows and more

CAI
Today at 16:00

CAI International - CAI Conference Calls
RBBN
Today at 16:30

Ribbon Communications - RBBN Conference Calls
SEDG
Today at 16:30

SolarEdge - SEDG Conference Calls
EVTC
Today at 16:30

Evertec - EVTC Conference Calls
GHDX
Today at 16:30

Genomic Health - GHDX Conference Calls
SREV
Today at 16:30

ServiceSource - SREV Conference Calls
MESO
Today at 16:30

Mesoblast - MESO Conference Calls
CUTR
Today at 16:30

Cutera - CUTR Conference Calls
A
Today at 16:30

Agilent - A Conference Calls
AXTI
Today at 16:30

AXT Inc. - AXTI Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	AI X AI Arlington Asset Investment Spot Secondary Managers: Morgan Stanley & JMP Securities Priced at: $8.33 6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ARR X ARR ARMOUR Residential Spot Secondary Managers: Morgan Stanley & Barclays, Citi, Credit Suisse, Goldman Sachs & JPMorgan Priced at: $20.33 7.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CPT X CPT Camden Property Spot Secondary Managers: BofA/Merrill & Deutsche Bank Priced at: $97.85 3.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NRZ X NRZ New Residential Spot Secondary Managers: Morgan Stanley, Credit Suisse & JPMorgan Priced at: $16.50 40.3M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OVID X OVID Ovid Therapeutics Spot Secondary Managers: Cowen & William Blair Priced at: $2.00 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SNNA X SNNA Sienna Biopharmaceuticals Spot Secondary Managers: Cowen & BMO Capital Priced at: $2.50 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Eli Lilly reports Q3 Humalog revenue down 5% to $664.6M

TODAY'S FREE FLY STORIES

Get Full Fly Access